We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors. ×
Market Research Report

Global Ultrasonic Nebulizer Market Outlook 2030: Market Segmentation By Product Type, By Volume, By Distribution Channels, By End-UserBy Geography With COVID-19 impact | Forecast Period 2017-2030

Published Date :

2020-09-01

Report Pages :

765

Format :

PDF

Region Covered :

Global

Global Ultrasonic Nebulizer Market Overview

Nebulizers are used to convert liquids into aerosols that can be inhaled in the lower respiratory tract utilizing the process of atomization. Ultrasonic nebulizers have been introduced in 1960, small volume of ultrasonic nebulizers were commercially available for delivery of inhaled bronchodilators because bronchodilators response was greater with ultrasonic nebulizers than the aerosol generators. Delivery of inhaled antibiotics in patients with cystic fibrosis is responsible to contribute for larger volume of ultrasonic nebulizers.  

According to American Academy of Allergy Asthma & Immunology and Cystic Fibrosis Foundation, worldwide 70,000 people suffered from cystic fibrosis in 2008 and that number keep on growing at the higher rate. Lumiscope portable ultrasonic nebulizer is portable and features two-valve system that ensures maximum efficiency of inhalation, thus reducing the waste of medication, commonly use by an adult or pediatric patient to produce medicated aerosols for inhalation therapy.

Global Ultrasonic Nebulizer Market Segmentation

  • By Product Type
  • Portable
  • Stand Alone
  • By Volume
  • Small-volume ultrasonic nebulizer
  • Large volume ultrasonic nebulizer
  • By Distribution Channels
  • Online    
  • Offline
  • By End-User
  • Hospitals
  • Ambulatory Surgical Centers
  • Home Settings
  • By Geography
  • North America (US, Canada) {Market Share (%), Market Size (USD Billion), Production (Units)}
  • Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Production (Units)}
  • Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion), Production (Units)}
  • Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Production (Units)}
  • Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Production (Units)}
  • Rest of the World {Market Share (%), Market Size (USD Billion), Production (Units)}

Growth Drivers and Challenges

The major drivers of global ultrasonic nebulizer market are they require less patient coordination, small dead volume, possibility of high doses, less accumulation of aerosol, no release of chlorofluorocarbon and faster drug delivery. Modification in the design of ultrasonic nebulizer to enhance the performance and reduction of the size of the droplets generated within or below the respirable range along with no concentrating or diluting effect during nebulization tends to propel the ultrasonic nebulizer market. In addition, rising cases of acute respiratory disorders, concentrated environment with pollution, cold climate and self administration facility fuel the ultrasonic nebulizer market.

Cost-ineffectiveness, possibility of contamination, prone to electrical and mechanical breakdown, availability of less drug formulations and requirement of drug preparation hampers the usage of ultrasonic nebulizers and hence impacting its market.  Increasing usage of metered-dose inhalers and dry powder inhalers tends to disturb the ultrasonic nebulizer market. Production of heat waves that can denature the thermally sensitive inhaled drugs limits the growth of ultrasonic nebulizer market. 

Market Size and Forecast (2017-2030)

The global nebulizer market is expected to generate the total revenue of USD 1.35 billion by 2024 and is poised to grow at a CAGR of 7.8% over the forecast period. The global ultrasonic nebulizer market is anticipated to grow at a CAGR of 6.24% over the forecast period of 2017-2030 owing to the high frequency medication delivery.

On the basis of product type, portable ultrasonic nebulizers dominate by 68% market share owing to the self-administration feature. Online distribution channel is expected to dominate the ultrasonic nebulizer market in the forecast period due to the increasing availability of online portal for nebulizers like JustNebulizer, etc.

Geographically, North America accounted for 35% ultrasonic nebulizer market share followed by Europe (25%), APAC (22%), Latin America (10%) and MEA (8%) in 2016. Although the ultrasonic nebulizer market is mature in North America but it will grow constantly owing to the prevalence of acute respiratory disorders. Europe is the second largest market of ultrasonic nebulizer followed by APAC owing to the high quality of nebulization – even highly viscose liquids such as beeswax.

Covered in this Global Ultrasonic Nebulizer Market Report

Market Synopsis

Market Segmentation

Global ultrasonic nebulizer market is segmented as follows:

  • By  product type (Market Size, Demand Analysis and Growth Analysis)
  • By  volume (Market Size, Demand Analysis and Growth Analysis)
  • By distribution channel (Market Size, Demand Analysis and Growth Analysis)
  • By end-user (Market Size, Demand Analysis and Growth Analysis)

Global ultrasonic nebulizer market report covered insights of below mentioned regions:

  • North America (U.S., Canada) {Market Size, Growth Analysis and Opportunity Analysis}
  • Latin America (Argentina, Mexico, Brazil and Rest of Latin America) {Market Size, Growth Analysis and Opportunity Analysis}
  • Europe (Germany, Italy, Spain, France, The U.K., Netherlands, Sweden, Hungary, Russia, Poland, Rest of Europe) {Market Size, Growth Analysis and Opportunity Analysis}
  • Asia-Pacific (China, India, Singapore, Japan, Australia, New Zealand, South Korea and Rest of Asia Pacific) {Market Size, Growth Analysis and Opportunity Analysis}
  • Middle East and North Africa (MENA) {Market Size, Growth Analysis and Opportunity Analysis}
  • Rest of World  {Market Size, Growth Analysis and Opportunity Analysis}

Market Dynamics: Growth Drivers, Restraints and Opportunities

  • Risk Factors
  • Regional Variations
  • Recent Trends and Developments

COVID-19 imapct on "Global Ultrasonic Nebulizer Market "    

Impact of COVID-19 Outbreak on “Global Ultrasonic Nebulizer Market ”, Manufacturers, Contract Manufacturers Suppliers and Recovery Strategy. A complete detailed chapter of 50-70 pages which includes the data and information focused on impacts of the pandemic on the Global Ultrasonic Nebulizer Market . It also showcases the expected recovery schedule and losses in the industry and other various major factors.

Key Market Players

  • Philips Healthcare

o Synopsis

o Business Strategy

o Product Portfolio

o SWOT Analysis

  • Omron Healthcare Co
  • Agilent Technologies, Inc. Ltd
  • Bio-Rad
  • Briggs Healthcare
  • GE Healthcare
  • Mabis DMI

Porter’s Five Force Model

Market Landscape: Competition and Beyond

Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem

Expert Analysis

Concluding Remarks




{ }

Global Ultrasonic Nebulizer Market Outlook 2030: Market Segmentation By Product Type, By Volume, By Distribution Channels, By End-UserBy Geography With COVID-19 impact | Forecast Period 2017-2030

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747

Table of Contents

Please Select Linenece Type